tiprankstipranks
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Cash flow

Compare
115 Followers

Sinovac Biotech Cash Flow

SVA's free cash flow for Q1 2024 was $93.26M. For the 2024 fiscal year, SVA's free cash flow was decreased by $1.13B and operating cash flow was $146.01M. See a summary of the company’s cash flow.
Cash Flow
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 104.00M$ -770.75M$ 15.35B$ 479.31M$ 39.07M
Investing Cash Flow
$ -2.93B$ -5.76B$ -3.02B$ -204.76M$ -42.45M
Financing Cash Flow
$ -76.06M$ -241.40M$ -1.90B$ 592.57M$ 1.74M
End Cash Position
$ 1.28B$ 4.29B$ 11.62B$ 1.05B$ 155.88M
Free Cash Flow
$ -41.69M$ -1.17B$ 14.63B$ 351.66M$ 28.45M
Currency in USD

Sinovac Biotech Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis